Literature DB >> 1991176

Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation.

J D Down1, N J Tarbell, H D Thames, P M Mauch.   

Abstract

Murine bone marrow chimera models were used to assess the efficacy of host total body irradiation (TBI) given at different doses, dose rates, and fractionation schemes in providing for engraftment of syngeneic and allogeneic bone marrow. B6-Hbbd congenic and LP mice, respectively, were used as donors (10(7) bone marrow cells) for syngeneic and allogenic (H-2 compatible) transplantation in standard B6 recipients. Stable marrow chimerism was determined from host and donor stem cell-derived hemoglobin phenotypes (Hbbs and Hbbd) on gel electrophoresis at 3 months posttransplant. Partial engraftment of syngeneic marrow was seen at single doses as low as 2 Gy, with the donor component increasing steadily with increasing TBI dose to a level of 100% at 7 Gy. Immunologic resistance of the host appeared to prevent allogeneic engraftment until 5.5 Gy. A very steep radiation dose response was then observed so that the level of chimerism with 6 Gy and above became comparable with syngeneic engraftment. Low dose rate (5 cGy minute-1) and fractionated TBI required higher total doses for equivalent engraftment (radiation dose-sparing) in both syngeneic and allogenic bone marrow transplantation. This displacement in the dose-response curve on fractionation was seen with interfraction intervals of 3 and 6 hours. A further dose-sparing effect was observed on extending the interval to 18 and 24 hours, but only for allogeneic transplantation, and may therefore be related to recovery of immune-mediated graft resistance. The involvement of multiple target cell populations in determining allogenic engraftment rendered the application of the linear-quadratic model for radiation cell survival problematic in this case. The recovery in dose when low dose rate and 6-hour interfraction intervals were applied in either syngeneic or allogeneic BMT is consistent with appreciable sub-lethal damage repair in the primitive self-renewing stem cell population of the host marrow. These results contrast with the poor repair capacity of the 11-day spleen colony-forming units (CFUs) population after fractionated irradiation and support the notion that ablation of early stem cells in the pre-CFUs compartment is essential for long-term marrow engraftment.

Entities:  

Mesh:

Year:  1991        PMID: 1991176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Leukodystrophy and bone marrow transplantation: role of mixed hematopoietic chimerism.

Authors:  C L Kaufman; S T Ildstad
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury.

Authors:  Andreas Patsalos; Attila Pap; Tamas Varga; Gyorgy Trencsenyi; Gerardo Alvarado Contreras; Ildiko Garai; Zoltan Papp; Balazs Dezso; Eva Pintye; Laszlo Nagy
Journal:  J Physiol       Date:  2017-08-08       Impact factor: 5.182

3.  Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.

Authors:  Kyle Peake; John Manning; Coral-Ann Lewis; Christine Barr; Fabio Rossi; Charles Krieger
Journal:  J Vis Exp       Date:  2015-04-01       Impact factor: 1.355

4.  Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.

Authors:  T E Druley; R Hayashi; D B Mansur; Q Jean Zhang; Y Barnes; K Trinkaus; S Witty; T Thomas; E E Klein; J F DiPersio; D Adkins; S Shenoy
Journal:  Bone Marrow Transplant       Date:  2008-11-17       Impact factor: 5.483

5.  Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation.

Authors:  Samuel Herberg; Galina Kondrikova; Khaled A Hussein; Sudharsan Periyasamy-Thandavan; Maribeth H Johnson; Mohammed E Elsalanty; Xingming Shi; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

6.  Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.

Authors:  Yue Yang; Nikolas L Jorstad; Christine Shiao; Makenzie K Cherne; Shawn B Khademi; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-04-06       Impact factor: 3.362

Review 7.  Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies.

Authors:  Raimon Duran-Struuck; Robert C Dysko
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-01       Impact factor: 1.232

Review 8.  The role of apoptosis-induced proliferation for regeneration and cancer.

Authors:  Hyung Don Ryoo; Andreas Bergmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 9.  Bone marrow chimeras-a vital tool in basic and translational research.

Authors:  Filipa M Ferreira; Pushpalatha Palle; Johannes Vom Berg; Prajwal Prajwal; Jon D Laman; Thorsten Buch
Journal:  J Mol Med (Berl)       Date:  2019-04-26       Impact factor: 4.599

10.  Correlation of plasma FL expression with bone marrow irradiation dose.

Authors:  Mary Sproull; Dane Avondoglio; Tamalee Kramp; Uma Shankavaram; Kevin Camphausen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.